A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.
Crit. Care Med. 2010 Aug 1;38(8):1685-94.
Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
Blood Purif. 2010 Jan 1;29(2):191-6.
Novel therapies for sepsis: a review.
J Trauma. 2005 Apr 1; 58 (4): 867-74.